| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |